PHARMAGREEN BIOTECH INC. Proceeds from Common Stock Issued
PHARMAGREEN BIOTECH INC. reported Proceeds from Common Stock Issued of $0 for the 9-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2023-08-14
- PHARMAGREEN BIOTECH INC. proceeds from issuance of common stock for the quarter ending 2023-06-30 was $0.00.
- PHARMAGREEN BIOTECH INC. proceeds from issuance of common stock for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- PHARMAGREEN BIOTECH INC. proceeds from issuance of common stock for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- PHARMAGREEN BIOTECH INC. proceeds from issuance of common stock for the quarter ending 2022-06-30 was -$6.50K, a 110.24% decline year-over-year.
- PHARMAGREEN BIOTECH INC. proceeds from issuance of common stock for fiscal 2020 was $570.08K, a 660.10% increase from fiscal 2019.
- PHARMAGREEN BIOTECH INC. proceeds from issuance of common stock for fiscal 2019 was $75.00K, a 74.85% decline from fiscal 2018.
- PHARMAGREEN BIOTECH INC. proceeds from issuance of common stock for fiscal 2018 was $298.24K.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 3 month as first filed | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $0.00 derived: sum of 2 quarters · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-19 | $0.00 10-Q · filed 2023-05-19 | |||||
| 2022-12-31 | $0.00 10-Q · filed 2023-02-14 | ||||||
| 2022-06-30 | -$6.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $20.00K derived: sum of 2 quarters · filed 2023-08-14 | $112.00K 10-Q · filed 2023-08-14 | ||||
| 2022-03-31 | $26.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-19 | $118.50K 10-Q · filed 2023-05-19 | |||||
| 2022-01-19 | $20.00K 10-Q · filed 2022-02-22 | ||||||
| 2021-12-31 | $92.00K 10-Q · filed 2023-02-14 | $100.00K 10-Q · filed 2022-02-22 | |||||
| 2021-06-30 | $63.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-18 | $186.72K 10-Q · filed 2021-08-18 | |||||
| 2021-03-31 | $123.22K 10-Q · filed 2021-05-24 | ||||||
| 2020-09-30 | $121.50K 10-Q · filed 2021-08-18 | $570.08K derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-08 | -$2.00 derived: sum of 2 quarters · filed 2021-08-18 | $435.33K derived: sum of 3 quarters · filed 2021-08-18 | $570.08K 10-K · filed 2021-01-08 | ||
| 2020-06-30 | -$570.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-18 | -$134.75K derived: sum of 2 quarters · filed 2021-08-18 | $0.00 10-Q · filed 2021-08-18 | $570.08K 10-Q · filed 2020-08-19 | |||
| 2020-03-31 | $435.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-19 | $570.08K 10-Q · filed 2020-05-19 | |||||
| 2019-12-31 | $134.75K 10-Q · filed 2020-02-18 | ||||||
| 2019-09-30 | $75.00K 10-K · filed 2021-01-08 | ||||||
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-30 | $298.24K 10-K · filed 2019-12-30 | |||||
| 2018-06-30 | $298.24K 10-Q · filed 2019-08-19 |